Healthcare Feb 08, 2023 11:44 AM (GMT+8) · EqualOcean
MacroLux (Chinese: 星辰海) announced that it had completed a nearly CNY 100 million Series A funding round, which was led by Legend Capital (Chinese: 君联资本) and followed by Dalton Venture (Chinese: 道彤投资). After this financing, MacroLux will accelerate to provide more solutions that meet global clients’ needs. Founded in 2020, MacroLux is a medical technology company providing innovative solutions for interventional endoscopic therapy. Endoscopic therapies has become highly important in many diseases such as digestion disease, respiratory disease, and urology disease. Single-use electronic endoscope has higher efficiency, lower costs than traditional endoscope, and can avoid cross infection. So MacroLux is dedicated to the product development and technology innovation of single-use endoscope.